RECRUITING

We Care About Brooklyn - A Digital Behavioral Intervention to Optimize Engagement in Maternal Healthcare

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to test a behavioral intervention in pregnant women who identify as Black and live in Central Brooklyn. The main question it aims to answer is whether the WeCAB intervention leads to a net improvement in utilization of postpartum care compared to those receiving usual care. The WeCAB group will have a dedicated WeCAB community health worker who will be trained in digital care navigation. Researchers will compare the WeCAB group versus the group receiving usual care to see if the patients randomized to WeCAB will have higher rates of early post-partum care compared to patients in the control group.

Official Title

Brooklyn Digital Community Care Intervention to Address Unmet Social Needs and Optimize Engagement in Maternal Health Care

Quick Facts

Study Start:2023-11-20
Study Completion:2024-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05916534

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 49 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Eligible participants for the pilot RCT will be patients
  2. * aged 18-49 years (childbearing age)
  3. * residing in a Central Brooklyn zip code
  4. * self-reporting as Black,
  5. * who speak English or Haitian Creole, and
  6. * plan to deliver or present for delivery at University Hospital at Downstate (UHD).
  7. * In NYC, SMM increases incrementally with later entry into prenatal care (1st trimester: 208/10,000 deliveries; 2nd trimester: 252/10,000; 3rd trimester: 297/10,000; None: 575/10,000). 3 Accordingly, in order to capture the full range of SMM risk profiles for our pilot study, any pregnant patient/client visiting our clinics will be eligible for enrollment from 13 weeks gestation through delivery, thus allowing follow-up to 3 months post-partum within the 2-year study timeline.
  1. * Patients planning to move outside of New York City in the ensuing 3 months post-partum
  2. * Patients demonstrating an impairment that limits their ability to provide informed consent.

Contacts and Locations

Study Contact

Aimee Afable, PHD
CONTACT
718-270-6397
aimee.afable@downstate.edu
Sandra Bruening, MS
CONTACT
518-217-2531
sandra.bruening@downstate.edu

Principal Investigator

Aimee Afable, PHD
PRINCIPAL_INVESTIGATOR
SUNY Downstate

Study Locations (Sites)

University Hospital at Downstate
Brooklyn, New York, 11203
United States

Collaborators and Investigators

Sponsor: State University of New York - Downstate Medical Center

  • Aimee Afable, PHD, PRINCIPAL_INVESTIGATOR, SUNY Downstate

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-11-20
Study Completion Date2024-08

Study Record Updates

Study Start Date2023-11-20
Study Completion Date2024-08

Terms related to this study

Keywords Provided by Researchers

  • Digital

Additional Relevant MeSH Terms

  • Maternal Health
  • Pregnant Women